🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Split 2:1 del 28/01/2013

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

6.181.783

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER ⓘ
—
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 3 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
13/12/2018 0,5700 USD
13/09/2018 0,5700 USD
14/06/2018 0,5700 USD
15/03/2018 0,5700 USD
14/12/2017 0,5200 USD
14/09/2017 0,5200 USD
14/06/2017 0,5200 USD
14/03/2017 0,5200 USD
13/12/2016 0,4700 USD
14/09/2016 0,4700 USD
14/06/2016 0,4700 USD
14/03/2016 0,4300 USD
14/12/2015 0,4300 USD
14/09/2015 0,4300 USD
12/06/2015 0,4300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
28/01/2013 2:1
25/06/2007 2:1
07/09/2004 2:1
08/03/2002 2:1
22/02/2001 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/05/2015 103,45 103,83 101,52 102,27 -0,70% 2,23% 10.065.200
05/05/2015 105,30 105,73 102,73 102,99 -2,53% 2,85% 15.046.500
04/05/2015 105,65 107,50 105,22 105,66 +0,62% 2,16% 13.215.600
01/05/2015 103,20 106,34 102,50 105,01 +4,48% 3,72% 22.306.500
30/04/2015 102,15 102,70 99,80 100,51 -1,77% 2,84% 14.009.500
29/04/2015 103,12 103,90 101,62 102,32 -1,35% 2,21% 8.932.200
28/04/2015 103,12 103,83 101,14 103,72 +0,76% 2,61% 9.793.700
27/04/2015 104,18 104,53 102,01 102,94 -0,73% 2,42% 10.829.200
24/04/2015 104,64 105,68 103,60 103,70 -1,44% 1,99% 9.734.400
23/04/2015 104,64 105,75 104,01 105,21 +0,99% 1,66% 8.071.800
22/04/2015 105,24 105,42 103,83 104,18 -0,97% 1,51% 8.267.300
21/04/2015 101,42 105,71 100,89 105,20 +4,51% 4,75% 19.722.700
20/04/2015 102,28 102,28 100,41 100,66 -0,71% 1,83% 8.752.000
17/04/2015 102,35 102,81 100,61 101,38 -1,90% 2,15% 9.896.500
16/04/2015 103,95 104,72 103,11 103,34 -0,66% 1,55% 6.670.400
15/04/2015 102,39 104,36 102,33 104,03 +1,78% 1,98% 12.899.700
14/04/2015 102,34 102,66 101,47 102,21 -0,07% 1,16% 7.224.700
13/04/2015 102,01 103,82 102,00 102,28 +0,50% 1,78% 10.648.400
10/04/2015 101,75 102,45 101,06 101,77 +0,60% 1,37% 9.257.600
09/04/2015 100,17 101,18 99,92 101,16 +1,29% 1,26% 9.178.100
08/04/2015 98,70 100,90 98,56 99,87 +1,20% 2,37% 10.967.100
07/04/2015 98,28 99,74 98,01 98,69 +0,92% 1,76% 8.264.700
06/04/2015 97,92 98,74 97,19 97,79 -0,65% 1,58% 9.697.300
02/04/2015 97,99 99,50 97,01 98,43 +0,73% 2,54% 10.727.300
01/04/2015 98,16 98,16 95,38 97,72 -0,42% 2,83% 15.134.200
31/03/2015 100,01 100,20 98,07 98,13 -2,54% 2,13% 13.559.900
30/03/2015 101,12 101,66 99,57 100,69 -0,31% 2,07% 9.968.200
27/03/2015 101,00 102,10 100,90 101,00 -0,08% 1,19% 8.815.900
26/03/2015 99,13 101,82 98,59 101,08 +1,22% 3,26% 10.928.000
25/03/2015 101,99 103,11 99,78 99,86 -1,53% 3,27% 15.629.300